SHANNA GAMBLE: Open Payments
NPI 1043859093 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 74 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $668 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $357 |
| ABBVIE INC. | 17 | $267 |
| Madrigal Pharmaceuticals | 7 | $159 |
| Janssen Biotech, Inc. | 10 | $135 |
| Ipsen Biopharmaceuticals, Inc | 7 | $130 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 9 | $75 |
| QOL Medical, LLC | 2 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $35 |
Products named: ENTYVIO, REZDIFFRA, TREMFYA, IQIRVO, RINVOQ, DUPIXENT, VOQUEZNA, Sucraid.
Industry payments across TX — which companies pay providers there.
